Enrolling By Invitation OBSERVATIONAL NCT07035067
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
Sponsor: PeriPharm
Conditions
Caregiver Burden Ovarian Cancer Patient Burden
Interventions
No intervention
Updated 3 times since 2025 Last updated: Dec 22, 2025 Started: Jul 15, 2025 Primary completion: May 31, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Caregiver Burden and Ovarian Cancer, this trial is ongoing. The trial is conducted by PeriPharm and has accumulated 3 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
3 versions recorded-
Jan 2026 — Present [monthly]
Enrolling By Invitation
-
Aug 2025 — Jan 2026 [monthly]
Enrolling By Invitation
-
Jul 2025 — Aug 2025 [monthly]
Enrolling By Invitation
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- PeriPharm
Data source: PeriPharm
For direct contact, visit the study record on ClinicalTrials.gov .